Abstract
CD4+CD25+ regulatory T cells exert an immune regulatory function and thus play an important role in the control of self-reactivity in the pathogenesis of autoimmune inflammatory conditions. The aim of the study presented here is to perform a quantitative and functional analyses of these cells in patients with autoimmune sensorineural hearing loss (ASNHL). T cell subsets (CD4+CD25+, CD4+CD25high, CD4+, and CD8+) from the peripheral blood of 17 patients with ASNHL, 16 patients with noise induced hearing loss (NHL), and 100 normal controls were analyzed by flow cytometry. The CD4/CD8 ratio was also analyzed. In addition, the suppressive capability of CD4+CD25+ T cells was tested in vitro by measuring their ability to suppress the proliferation and IFN-γ secretion of CD4+CD25− T cells. No significant difference was found in the T cell subsets of ASNHL patients compared to normal controls or NHL patients, except that the proportion of CD4+ T cells was elevated in ASNHL patients. However, we did observe defective regulatory function of CD4+CD25+T cells in patients with ASNHL. Our data supported the idea that CD4+CD25+ regulatory T cells played an immunosuppressive function in the periphery. The impaired suppressive activity of these cells may be an important factor in the pathogenesis of ASNHL.
Similar content being viewed by others
References
McCabe BF (1979) Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 88:585–589
Solares CA, Hughes GB, Tuohy VK (2003) Autoimmune sensorineural hearing loss: an immunologic perspective. J Neuroimmunol 138:1–7
McCabe BF, McCormick KJ (1984) Tests for autoimmune disease in otology. Am J Otol 5:447–449
Lorenz RR, Solares CA, Williams P, Sikora J, Pelfrey CM, Hughes GB, Tuohy VK (2002) Interferon-gamma production to inner ear antigens by T cells from patients with autoimmune sensorineural hearing loss. J Neuroimmunol 130:173–178
Yamanobe S, Harris JP (1992) Spontaneous remission in experimental autoimmune labyrinthitis. Ann Otol Rhinol Laryngol 101:1007–1014
Gloddek B, Gloddek J, Arnold W (1999) A rat T-cell line that mediates autoimmune disease of the inner ear in the Lewis rat. ORL J Otorhinolaryngol Relat Spec 61:181–187
Ito Y, Nieda M, Uchigata Y, Nishimura M, Tokunaga K, Kuwata S et al (1993) Recognition of human insulin in the context of HLA-DRB1*0406 products by T cells of insulin autoimmune syndrome patients and healthy donors. J Immunol 151:5770–5776
Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA (1990) T-cell recognition of an immunodominant myelin basic protein epitope inmultiple sclerosis. Nature 346:183–187
Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151–1164
O’Garra A, Vieira P (2004) Regulatory T cells and mechanisms of immune system control. Nat Med 10:801–805
Li Z, Mahesh SP, Kim BJ, Buggage RR, Nussenblatt RB (2003) Expression of glucocorticoid induced TNF receptor family related protein (GITR) on peripheral T cells from normal human donors and patients with non-infectious uveitis. J Autoimmun 21:83–92
Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA (2001) CD4+CD25+ high regulatory cells in human peripheral blood. J Immunol 167:1245–1253
Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH (2001) Identification and functional characterization of human CD4 (+)CD25 (+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 193:1285–1294
Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA (2004) Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 199:971–979
Cao D, Malmstrom V, Baecher-Allan C, Hafler D, Klareskog L, Trollmo C (2003) Isolation and functional characterization of regulatory CD25 bright CD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 33:215–223
Kukreja A, Cost G, Marker J, Zhang C, Sun Z, Lin-Su K et al (2002) Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 109:131–140
Harris JP, Weisman MH, Derebery JM, Espeland MA, Gantz BJ, Gulya AJ et al (2003) Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial. JAMA 290:1875–1883
Baek MJ, Park HM, Johnson JM, Altuntas CZ, Jane-Wit D, Jaini R et al (2006) Increased frequencies of cochlin-specific t cells in patients with autoimmune sensorineural hearing loss. J Immunol 177:4203–4210
Cao D, van Vollenhoven R, Klareskog L, Trollmo C, Malmström V (2004) CD25 bright CD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res Ther 6:335–346
Jiang S, Camara N, Lombardi G, Lechler RI (2003) Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex-vivo. Blood 102:2180–2186
Sakaguchi S (2005) Naturally arising FoxP3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6:343–352
Shevach EM (2004) Regulatory/suppressor T cells in health and disease. Arthritis Rheum 50:2721–2724
Kusakari C, Hozawa K, Koike S, Kyogoku M, Takasaka T (1992) MRL/Mp-lpr/lpr mouse as a model of immune-induced sensorineural hearing loss. Ann Otol Rhinol Laryngol Suppl 157:82–86
Monk CR, Spachidou M, Rovis F, Leung E, Botto M, Lechler RI et al (2005) MRL/Mp CD4+,CD25-T cells show reduced sensitivity to suppression by CD4+,CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus. Arthritis Rheum 52:1180–1184
Yang M, Zheng J, Yang Q, Yao H, Chen Y, Tan H et al (2004) Frequency-specific association of antibodies against heat shock proteins 0 and 70 with noise-induced hearing loss in Chinese workers. Cell Stress Chaperones 9:207–213
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Xia, M., Zhang, H.B., Liu, F. et al. Impaired CD4+CD25+ regulatory T cell activity in the peripheral blood of patients with autoimmune sensorineural hearing loss. Eur Arch Otorhinolaryngol 265, 1027–1033 (2008). https://doi.org/10.1007/s00405-007-0565-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-007-0565-9